Scrip
Will combining GSK and Pfizer HIV businesses boost new therapies?
22 April 2009
Katie McQue
Please Login to read the full article.
22 April 2009
Katie McQue
In an effort to become the market leader for HIV, GlaxoSmithKline and Pfizer have merged their antiretroviral portfolios to create a so-far unnamed London-based speciality company led by GSK's Dr Dominique Limet, with 11 marketed products and another six in the clinical pipeline.
The...
Please Login to read the full article.
RELATED CONTENT
NEWS
- 2009 results preview: big pharma grapples to varying degrees of success with generic erosion
- GSK's profits up by 12%, but US business continues to falter
- UK MPs wants pharma in AIDS patent pool, while GSK makes new moves
- GSK and Pfizer to create together a HIV-focused company
COMMENT
Other Informa Comment
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
